Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Anja Lendvay"'
Autor:
Vera Halpern, Angie Wheeless, Vivian Brache, Anja Lendvay, Leila Cochón, Douglas Taylor, Laneta J. Dorflinger
Publikováno v:
Contraception: X, Vol 5, Iss , Pp 100100- (2023)
Objectives: This study aimed to evaluate and compare local tolerability of investigational drug TV-46046 and reference drug Depo-subQ Provera 104, both containing medroxyprogesterone acetate (MPA) as an active ingredient. Study design: We conducted a
Externí odkaz:
https://doaj.org/article/7c14e39b14a34d94aed2b06c025acc18
Autor:
Vera Halpern, Rachael Fuchs, Vivian Brache, Luis Bahamondes, Maria Jose Miranda, Anja Lendvay, Leila Cochón, Douglas Taylor, Laneta J. Dorflinger
Publikováno v:
Contraception: X, Vol 3, Iss , Pp 100070- (2021)
Objectives: To identify the lowest dose of Depo-Provera that, when administered off-label subcutaneously, suppressed ovulation and had a pharmacokinetic profile consistent with a 4-month contraceptive effect.Study Design: We conducted a randomized, m
Externí odkaz:
https://doaj.org/article/52a60f16f00c44a0b05c536e40d343dd
Autor:
Paul J Feldblum, Adesina Adeiga, Rashidi Bakare, Silver Wevill, Anja Lendvay, Fatimah Obadaki, M Onikepe Olayemi, Lily Wang, Kavita Nanda, Wes Rountree
Publikováno v:
PLoS ONE, Vol 3, Iss 1, p e1474 (2008)
The objective of this trial was to determine the effectiveness of 1.0% C31G (SAVVY) in preventing male-to-female vaginal transmission of HIV infection among women at high risk.This was a Phase 3, double-blind, randomized, placebo-controlled trial. Pa
Externí odkaz:
https://doaj.org/article/416e836ecbd04ff4948a9a97aa7571b5
Autor:
Leila Cochon, Vera Halpern, Jeffrey T. Jensen, Vivian Brache, Laneta J. Dorflinger, Douglas Taylor, Anja Lendvay
Publikováno v:
Fertility and Sterility
Objective To evaluate the pharmacokinetics and pharmacodynamics of medroxyprogesterone acetate after a single subcutaneous injection in the abdomen of 150 or 300 mg Depo-Provera and compare results to two injections of Depo-SubQ Provera 104 given 3 m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2215eea9d76839647e6d816db913a98c
http://europepmc.org/articles/PMC8051852
http://europepmc.org/articles/PMC8051852
Autor:
Leila Cochon, Luis Bahamondes, Anja Lendvay, Rachael Fuchs, Douglas Taylor, Maria Jose Miranda, Laneta J. Dorflinger, Vera Halpern, Vivian Brache
Publikováno v:
Contraception: X, Vol 3, Iss, Pp 100070-(2021)
Contraception: X
Contraception: X
Objectives To identify the lowest dose of Depo-Provera that, when administered off-label subcutaneously, suppressed ovulation and had a pharmacokinetic profile consistent with a 4-month contraceptive effect. Study design We conducted a randomized, mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f909b0b1107df5b5abe12622851a64cd
http://www.sciencedirect.com/science/article/pii/S2590151621000174
http://www.sciencedirect.com/science/article/pii/S2590151621000174
Publikováno v:
Obstetrics & Gynecology. 123:1012-1022
OBJECTIVE:: To estimate whether continuous combined oral contraceptive pill (OCP) use leads to higher continuation and lower pregnancy rates over 12 months than cyclic use in a developing country setting. METHODS:: We enrolled healthy women aged 18 t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42efd94aee23f6c9f702276aac0a7407
https://doi.org/10.1097/aog.0000000000000235
https://doi.org/10.1097/aog.0000000000000235
Autor:
Kevin McKenna, Fidele Ngabo, Anja Lendvay, Elizabeth E. Tolley, Emmanuel Munyambanza, Caroline Mackenzie, Jennet Arcara, Kate H Rademacher
Publikováno v:
Global Health, Science and Practice
High effectiveness, predictable return to fertility, and a single, prepackaged, disposable delivery system ranked high. Side effects were generally acceptable to women if they did not last long or disrupt daily activities. Cost was considered importa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f445e7a8c5aba2e9cc94b6f918393b8b
https://doi.org/10.9745/ghsp-d-13-00147
https://doi.org/10.9745/ghsp-d-13-00147
Autor:
Markus J. Steiner, Shiphrah Kuria, Mario Chen, Anja Lendvay, Rose Otieno-Masaba, Syed Khurram Azmat, Angie Wheeless, Babar Tasneem Shaikh, Paul J. Feldblum, Waqas Hameed
Publikováno v:
Contraception. 89(3):197-203
Background Sino-implant (II) is a two-rod subcutaneous contraceptive implant used up to 4 years, containing 150 mg of levonorgestrel. We conducted two observational studies of Sino-implant (II) to evaluate its performance in routine service delivery
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a52007d4996fe3fa6eb26b2d887eaf4
Autor:
Sarah Nakubulwa, Bernard Mpairwe, Cynthia Kwok, Vinodh A. Edward, Florence Mirembe, Anja Lendvay, Karine Dubé, Lebohang Molife, Sinead Delany-Moretlwe, Kavita Nanda
Publikováno v:
AIDS. 27:S17-S25
Objective: To evaluate the effect of nevirapine-containing antiretroviral therapy (ART) on combined oral contraceptive (COC) effectiveness. Design: Nonrandomized prospective clinical trial. Methods: We enrolled HIV-infected women aged 18–35 years i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15a6c7e4783fbcd23f26263343facc86
https://doi.org/10.1097/qad.0000000000000050
https://doi.org/10.1097/qad.0000000000000050
Autor:
K. Hopkins, Angie Wheeless, Markus J. Steiner, O. Hanitriniaina, Anja Lendvay, Paul J. Feldblum, Mario Chen
Publikováno v:
Contraception. 88:103-108
Background Sino-implant (II) is a low-cost subdermal contraceptive implant containing levonorgestrel that is currently labeled for 4 years of use. Widely used in China and Indonesia, it has been little studied elsewhere. We conducted a prospective st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b4e68f03dff3f2f45ad7da02810e92d
https://doi.org/10.1016/j.contraception.2013.03.006
https://doi.org/10.1016/j.contraception.2013.03.006